Empagliflozin (Jardiance) for type 2 diabetes mellitus

Research output: Contribution to journal › Comment/debate › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{294ea19a509b45b49c8289567375549f,

title = "Empagliflozin (Jardiance) for type 2 diabetes mellitus",

author = "Jay Zimmermann",

year = "2016",

month = dec,

day = "15",

language = "English (US)",

volume = "94",

pages = "1014--1015",

journal = "American family physician",

issn = "0002-838X",

publisher = "American Academy of Family Physicians",

number = "12",

}

TY - JOUR

T1 - Empagliflozin (Jardiance) for type 2 diabetes mellitus

AU - Zimmermann, Jay

PY - 2016/12/15

Y1 - 2016/12/15

UR - https://www.scopus.com/pages/publications/85006410507

UR - https://www.scopus.com/pages/publications/85006410507#tab=citedBy

M3 - Comment/debate

C2 - 28075091

AN - SCOPUS:85006410507

SN - 0002-838X

VL - 94

SP - 1014

EP - 1015

JO - American family physician

JF - American family physician

IS - 12

ER -